Etanautine
From Wikipedia, the free encyclopedia
Jump to navigation
Jump to search
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Etanautine" – news · newspapers · books · scholar · JSTOR (November 2014) (Learn how and when to remove this template message) |
![]() | |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C26H31N5O5 |
Molar mass | 493.564 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Etanautine, also known as diphenhydramine monoacefyllinate, is an anticholinergic used as an antiparkinsonian agent. It is a 1:1 salt of diphenhydramine with acefylline, similar to the diphenhydramine/8-chlorotheophylline combination product dimenhydrinate.
As with dimenhydrinate, the stimulant effect of the etanautine counteracts the sedative effect from the diphenhydramine, resulting in an improved therapeutic profile.
The 1:2 salt diphenhydramine diacefylline (with two molecules of acefylline to each molecule of diphenhydramine) is also used in medicine, under the brand name Nautamine.
References[edit]
Dopaminergics |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Anticholinergics | |||||||||||
Others | |||||||||||
|
Receptor (ligands) |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (blockers) |
| ||||||||||
Enzyme (inhibitors) |
| ||||||||||
Others | |||||||||||
See also: Receptor/signaling modulators |
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |